Paula Costa

Paula Costa

Auto-generated profile, based on publicly available information

Paula Costa

Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2009 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
HFH Fonseca
H Fonseca
ASAm Silva
Am Silva
MMMg Matos
Mg Matos
IEI Esteves
I Esteves
PCP Costa
P Costa
JGJ Gomes‐Pedro
J Gomes‐Pedro

22 January 2009 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
AMAna Filipa Mourão
Ana Filipa Mourão
JCJoana Caetano-Lopes
Joana Caetano-Lopes
PCPaula Costa
Paula Costa
HCHelena Canhao
Helena Canhao
MSMaria José Santos
Maria José Santos
João Eurico FonsecaJoão Eurico Fonseca
João Eurico Fonseca
Objective. Considering the relevance of tumor necrosis factor-α (TNF-α) in the pathophysiology of juvenile idiopathic arthritis (JIA), it is likely that polymorphisms in its promoter area may be relevant in disease susceptibility and activity. We investigated if clinical measures of JIA activity and TNF-α serum concentrations were associated with TNF-α −308 genotypes.

25 June 2019 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
Gustavo RochaGustavo Rocha
Gustavo Rocha
FLF. Flor de Lima
F. Flor de Lima
AMA. Paula Machado
A. Paula Machado
HGH. Guimarães
H. Guimarães
EPE. Proença
E. Proença
HGHypertensive Disorders of Pregnancy Study Group
Hypertensive Disorders of Pregnancy Study Group
INTRODUCTION: Several studies assessed the influence of a low birth weight on bronchopulmonary dysplasia (BPD), but not all could find a significant association. Our aim was to assess the association between low birth weight and BPD in preterm infants, prospectively recruited at 11 level III Portuguese neonatal centers. METHODS: Obstetrical and neonatal data on mothers and preterm infants with gestational ages between 24 and 30 weeks, born during 2015 and 2016 after a surveilled pregnancy, were analyzed. Neonates were considered small for gestational age (SGA) when their birthweight was below the 10th centile of Fenton's growth chats and BPD was defined as the dependency for oxygen therapy until 36 weeks of corrected age. Statistical analysis was performed using IBM SPSS® statistics 23 and a p-value <0.05 was considered statistically significant. RESULTS: Out of 614, a total of 494 preterm infants delivered from 410 women were enrolled in the study; 40 (8.0%) infants with SGA criteria. SGA were more often associated with a single pregnancy, had greater use of antenatal corticosteroids, increased prevalence of gestational hypertensive disorders, C-section, rupture of membranes below 18 hours, rate of intubation in the delivery room, use of surfactant treatment, oxygen therapy, mechanical ventilation need, BPD, cystic periventricular leukomalacia, nosocomial sepsis and pneumonia; had lower prevalence of chorioamnionitis, and lower Apgar scores. The multivariate analysis by logistic regression, adjusted for BPD risk factors revealed a significant association between SGA and BPD: OR = 5.2 [CI: 1.46–18.58]; p = 0.01. CONCLUSION: The results of this study increase the scientific evidence that SGA is an independent risk factor for BPD.

1 September 2009 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JPJoaquim Polido‐Pereira
Joaquim Polido‐Pereira
DFDaniel Ferreira
Daniel Ferreira
ARAna Maria Rodrigues
Ana Maria Rodrigues
CNCatarina Nascimento
Catarina Nascimento
PCPaula Costa
Paula Costa
João Eurico FonsecaJoão Eurico Fonseca
João Eurico Fonseca

11 July 2018 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
FLFilipa Flor de Lima
Filipa Flor de Lima
AMAna Paula Machado
Ana Paula Machado
HGHercília Areias Guimarães
Hercília Areias Guimarães
Gustavo RochaGustavo Rocha
Gustavo Rocha
HGHypertensive Disorders of Pregnancy Study Group
Hypertensive Disorders of Pregnancy Study Group
CQConceição Quintas
Conceição Quintas
Introduction It is not yet fully known whether hypertensive disorders (HTD) during pregnancy impose an increased risk of development of bronchopulmonary dysplasia (BPD) in preterm newborn infants. Objective To test the hypothesis that preeclampsia and other HTD are associated with the development of BPD in preterm infants. Materials and Methods Data on mothers and preterm infants with gestational age 24 to 30 weeks were prospectively analyzed in 11 Portuguese level III centers. Statistical analysis was performed using IBM SPSS statistics 23. Results A total of 494 preterm infants from 410 mothers were enrolled, and 119 (28%) of the 425 babies, still alive at 36 weeks, developed BPD. The association between chronic arterial hypertension, chronic arterial hypertension with superimposed preeclampsia, and gestational hypertension in mothers and BPD in preterm infants was not significant (p = 0.115; p = 0.248; p = 0.060, respectively). The association between preeclampsia–eclampsia and BPD was significant (p = 0.007). The multivariate analysis revealed an association between preeclampsia–eclampsia and BPD (odds ratio [OR] = 4.6; 95% confidence interval [CI] 1.529–13.819; p = 0.007) and a protective effect for BPD when preeclampsia occurred superimposed on chronic arterial hypertension in mothers (OR = 0.077; 95%CI 0.009–0.632; p = 0.017). Conclusion The results of this study support the association of preeclampsia in mothers with BPD in preterm babies and suggest that chronic hypertension may be protective for preterm babies.

17 October 2011 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
PCPaula Catarino Costa
Paula Catarino Costa
CBCeleste Canha Barreto
Celeste Canha Barreto
LPLuisa Farinha Pereira
Luisa Farinha Pereira
MLMaria Luisa Lobo
Maria Luisa Lobo
MCMaria Adília Costa
Maria Adília Costa
ALAna Isabel Gouveia Lopes
Ana Isabel Gouveia Lopes
Prospective studies concerning liver disease in pediatric cystic fibrosis patients are scarce. The present study aimed to describe the prevalence and clinical expression of cystic fibrosis - related liver disease, in a cohort of 62 pediatric patients. Descriptive study, resulting from the prospective evaluation, between 1994 and 2009, of 62 pediatric patients (age <18 years) with cystic fibrosis. The follow-up protocol included a clinical assessment every 2 months, liver function tests every 6 months and annual liver ultrasonography. The cumulative prevalence of liver disease was 11.2% (7/62 cases). All patients had ΔF508 mutation and pancreatic insufficiency, none had meconium ileus. The liver involvement became clinically evident at a mean age of 8 years (3-15 years), revealed by hepatomegaly or hepatosplenomegaly (3 cases) and/ or abnormalities of liver function tests (3 cases) changes of liver ultrasound (7 cases) with evidence of portal hypertension (2 cases). Four patients were submitted to liver biopsy; biliary fibrosis was documented in one case, focal biliary cirrhosis in 2 cases and multilobular cirrhosis in another case. Within a median 11.6 years follow-up period (all patients under UDCA therapy after liver disease diagnosis), progression of liver disease was observed in 2 patients; one patient developed refractory variceal bleeding and progressive hepatic failure, requiring liver transplant. The results of the present study agree with those of previous pediatric studies, further documenting clinical expression of liver disease in CF patients, which is usually detected in the first decade of life and emphasize the contribution of ultrasound to early diagnosis of liver involvement. Moreover, although advanced liver disease is a relatively rare event, early isolated liver transplantation may have to be considered at this age group.